Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines

Published on December 24, 2024

Under the terms of their expanded agreement, both companies will co-fund research and development costs. Sanofi will pay EUR 50M upfront

Continue reading on website
Other news

Protester admits damaging Stone of Destiny display case at Edinburgh Castle

December 24, 2024
reduce the price of baby products and for the Scottish Government to fund food hubs. Madden appeared at Edinburgh Sheriff Court on Christmas

Baby mammoth preserved for 50,000 years is unveiled in Russia's Siberia

December 24, 2024
Eastern Federal University, which has a dedicated mammoth research center and museum.The university described the find as “exceptional”